Broadway Rose presents 'A Christmas Carol, The Musical'
Broadway Rose Theatre Co. is putting a Broadway spin on a Charles Dickens classic with an upcoming presentation of "A Christmas Carol, the Musical."
Performances kick off on Wednesday, Nov. 24, and continue through Dec. 23, at the Tigard theater located at 12850 S.W. Grant Ave.
"Bitter miser Ebenezer Scrooge has nearly humbugged his way through another Christmas Eve when the specter of his former partner, Jacob Marley, appears to warn him that three spirits will visit in the night to lead him through Christmases past, present and future," states a news release about the musical. "Through a sweeping score and whimsical storytelling, Scrooge seeks redemption for his selfish ways in time for a happy Christmas Day — lest he doom himself and others to a more chilling fate."
Dan Murphy, co-founder and managing director at Broadway Rose, and Annie Kaiser, direct the production based on the Dickens novella originally published in 1843.
The musical director is Darcy White, with choreography by Robert Head.
Paul Cosca portrays Scrooge and Francesco Germano is Tiny Tim. Robert Head, Emily Sahler, William Shindler, Valentina Silva, Tom Slate and Victoria Spelman play all the remaining characters.
Others who are part of the creative team in the Broadway Rose's "A Christmas Carol, the Musical" include Robert Vaughn, set designer; Blain Radford, lighting designer; Sydney Dufka, costume designer; James Sharinghousen, prop designer; Brian Karl Moen, sound designer; Jane Holmes, wig designer; and Jessica Junor, production stage manager.
For ticket info, visit broadwayrose.org.
This will be the third live show Broadway Rose Theatre Co. has produced since the COVID-19 pandemic began.
The first was "Analog & Vinyl," performed last summer. That performance provided theater-goers with a variety of viewing options including five fully open performances without restrictions (no face masks, no social distancing, during the governor's lifting of restrictions for a brief time) shown at full theater capacity, which made up 20% of sales. However, it was the 11 vaccinated performances, which included distance seating at 50% of theater capacity, which drew the most audience, making up 66% of total sales, according to Alan Anderson, marketing director for Broadway Rose.
The most recent Broadway Rose performance, an October production of "Loch Lomond," a tale set in the Scottish Highlands, was deemed a success, noted Anderson.
"We exceeded our sales goal by 22%, and seating was at 67% capacity," said Anderson. "The safety measures and protocols put in place were well received. Audience members expressed elation at being able to see a live show again after such a long break, and many patrons were quite emotional and grateful."
Meanwhile, Broadway Rose Theatre Co. is pushing forward with its expansion plans.
Those include adding a new studio and rehearsal space, a new costume/enlarged scenic shop and additional administrative offices.
Anderson said expansion has been slower than expected due to the weather and the discovery of "dry well" issues. However, construction crews began pouring foundations on Nov. 10.
"We now anticipate a spring completion," he said. "We continue to fundraise as costs have increased, and have $94,319 left to raise in the $3.5 million budget."
This story was updated to correct that Dan Murphy is a co-founder of Broadway Rose Theatre Co., not a co-owner.
You count on us to stay informed and we depend on you to fund our efforts. Quality local journalism takes time and money. Please support us to protect the future of community journalism.